phenylalanine has been researched along with h-tyrosyl-cyclo(cysteinyl-phenylalanyl-penicillaminyl)-oh in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bouzit, H; Hepp, AM; Heyl, DL; Johnson, TW; Kurtz, KR; Mousigian, C; Schmitter, SJ | 1 |
| Davis, P; Heyl, DL; Lomize, A; Mosberg, HI; Mousigian, C; Nordan, I; Omnaas, JR; Porreca, F | 1 |
| Fowler, CB; Mosberg, HI | 1 |
3 other study(ies) available for phenylalanine and h-tyrosyl-cyclo(cysteinyl-phenylalanyl-penicillaminyl)-oh
| Article | Year |
|---|---|
Substitution of aromatic and nonaromatic amino acids for the Phe3 residue in the delta-selective opioid peptide deltorphin I: effects on binding affinity and selectivity.
Topics: Amino Acid Sequence; Analgesics; Enkephalins; Kinetics; Molecular Sequence Data; Oligopeptides; Phenylalanine; Protein Conformation; Receptors, Opioid, delta; Receptors, Opioid, kappa; Receptors, Opioid, mu; Structure-Activity Relationship; Tritium | 1994 |
Development of a model for the delta opioid receptor pharmacophore. 2. Conformationally restricted Phe3 replacements in the cyclic delta receptor selective tetrapeptide Tyr-c[D-Cys-Phe-D-Pen]OH (JOM-13).
Topics: Amino Acid Sequence; Aminobutyrates; Animals; Cyclization; Enkephalins; Guinea Pigs; Ileum; Male; Mice; Molecular Sequence Data; Muscle Contraction; Phenylalanine; Protein Conformation; Receptors, Opioid, delta; Stereoisomerism; Structure-Activity Relationship; Thermodynamics; Vas Deferens | 1994 |
Development and validation of opioid ligand-receptor interaction models: the structural basis of mu vs delta selectivity.
Topics: Binding Sites; Binding, Competitive; Enkephalins; Ligands; Models, Molecular; Mutagenesis, Site-Directed; Peptides, Cyclic; Phenylalanine; Protein Binding; Protein Conformation; Radioligand Assay; Receptors, Opioid, delta; Receptors, Opioid, mu; Structure-Activity Relationship; Substrate Specificity | 2002 |